Kestra Medical Technologies Cash Flow Statement (2024-2026) | KMTS

Cash Flow Statement Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income (Quarter) -21.62M-19.93M-20.32M-20.62M-21.76M-46.27M-25.83M-32.78M-34.17M77.31M
Depreciation and Depletion (Quarter) 3.36M3.50M2.38M1.87M1.89M1.84M2.03M2.37M1.98M2.33M
Share-based Compensation (Quarter) 0.04M0.52M0.38M1.12M0.46M22.31M23.43M20.06M10.11M-21.73M
Gains from Investment Securities (Quarter) -2.91M0.84M-0.23M-0.38M
Cash from Operations (Quarter) -14.95M-17.50M-18.06M-18.00M-24.06M-26.27M-18.34M-18.37M-18.72M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.20M0.20M0.66M0.17M0.37M0.47M0.47M0.47M0.47M
Depreciation & Amortization (CF) (Quarter) 3.36M3.50M2.38M1.87M1.89M1.84M2.03M2.37M1.98M2.33M
Change in Working Capital
Change in Receivables (Quarter) 1.10M2.89M1.58M3.34M0.96M1.78M1.71M2.66M2.91M
Change in Account Payables (Quarter) 1.62M2.27M-2.61M4.01M-0.82M-2.90M0.52M1.73M4.95M
Change in Accured Expenses (Quarter) 1.15M0.14M1.65M0.94M1.89M-0.86M1.38M3.67M4.00M
Other Working Capital Changes (Quarter) -0.19M0.39M-0.34M0.38M1.42M-0.14M-0.81M0.53M0.98M
Investing Activities
Capital Expenditures (Quarter) -8.11M-0.01M11.49M-9.26M-0.34M-0.01M15.44M9.80M-24.81M
Cash from Investing Activities (Quarter) -4.16M-7.03M-4.42M-4.45M-7.40M-8.23M-7.42M-14.92M-172.71M
Financing Activities
Cash from Financing Activities (Quarter) 12.24M116.25M-0.57M-0.12M214.70M-1.88M-0.03M149.18M-0.18M
Additional items
Change in Cash (Quarter) -6.87M91.72M-23.05M-22.57M183.24M-36.38M-25.79M115.90M-191.61M
Free Cash Flow (Quarter) -6.84M-17.49M-29.55M-8.73M-23.71M-26.26M-33.78M-28.16M6.09M
Net Cash Flow (Quarter) -6.87M91.72M-23.05M-22.57M183.24M-36.38M-25.79M115.90M-191.61M